Methyl 4-(4-{[2-oxo-5-(trifluoromethyl)-1,2-dihydropyridin-1-yl]methyl}benzamido)benzoate

Catalog No. :
ACCLAR529
CAS No. :
339025-42-2
Molecular Formula :
C22H17F3N2O4
Molecular Weight :
430.38

IUPAC Name:methyl 4-(4-((2-oxo-5-(trifluoromethyl)pyridin-1(2H)-yl)methyl)benzamido)benzoate

Methyl 4-(4-{[2-oxo-5-(trifluoromethyl)-1,2-dihydropyridin-1-yl]methyl}benzamido)benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 4-(4-{[2-oxo-5-(trifluoromethyl)-1,2-dihydropyridin-1-yl]methyl}benzamido)benzoate
IUPAC Namemethyl 4-(4-((2-oxo-5-(trifluoromethyl)pyridin-1(2H)-yl)methyl)benzamido)benzoate
MDL No.MFCD00140607
Molecular FormulaC22H17F3N2O4
Molecular Weight430.38
SMILESO=C(OC)C1=CC=C(NC(C2=CC=C(CN3C=C(C(F)(F)F)C=CC3=O)C=C2)=O)C=C1
InChI KeyQMHBZKKFWADMOH-UHFFFAOYSA-N
SynonymMETHYL 4-[(4-([2-OXO-5-(TRIFLUOROMETHYL)-1(2H)-PYRIDINYL]METHYL)BENZOYL)AMINO]BENZENECARBOXYLATE;methyl 4-(4-{[2-oxo-5-(trifluoromethyl)-1,2-dihydropyridin-1-yl]methyl}benzamido)benzoate;Benzoic acid, 4-[[4-[[2-oxo-5-(trifluoromethyl)-1(2H)-pyridinyl]methyl]benzoyl]amino]-, methyl ester
CAS No.339025-42-2

Synthetic Route by SureRoute

1. ACCLAR529 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAQXN128 route compound structure diagram
    ACAQXN128619-45-4 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCLAR529 route product structure diagram
    ACCLAR529339025-42-2
Inquiry

2. ACCLAR529 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPVGH896 route compound structure diagram
    ACPVGH89633252-63-0 In Stock
  4. Then
  5. ACCLAR529 route product structure diagram
    ACCLAR529339025-42-2
Inquiry

Comments (0)